| Jul 31,
2017 | Jul 31,
2018 | Jul 31,
2019 | Jul 31,
2020 | Jul 31,
2021 | Jul 31,
2022 | Jul 31,
2023 | Jul 31,
2024 |
|---|
| Operating revenue | 300 | 200 | 100 | 2,100 | 1,400 | 23 | 2,350 | - |
|---|
| Research and development expenses | 349 | 453 | 640 | 1,357 | 1,524 | 1,421 | 1,567 | 1,454 |
|---|
| Selling, general and administrative expenses | 112 | 122 | 187 | 328 | 470 | 582 | 640 | 622 |
|---|
| Operating expenses | 461 | 575 | 827 | 1,684 | 1,994 | 2,004 | 2,208 | 2,076 |
|---|
| Operating profit (loss) | -161 | -375 | -727 | 416 | -594 | -1,981 | 142 | -2,076 |
|---|
| Interest and dividend income | 0 | 0 | 0 | 0 | 0 | - | - | - |
|---|
| Subsidy income | 4 | 52 | 10 | 13 | 13 | 0 | 1 | 0 |
|---|
| Foreign exchange gains | 0 | 0 | 0 | - | 0 | 0 | 1 | - |
|---|
| Fiduciary obligation income | - | - | - | - | - | 8 | - | - |
|---|
| Gain on sale of goods | - | - | - | - | - | - | 0 | 0 |
|---|
| Miscellaneous income | - | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
|---|
| Non-operating income | 4 | 53 | 10 | 13 | 13 | 9 | 3 | 0 |
|---|
| Interest expenses | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
|---|
| Miscellaneous losses | - | - | - | - | - | - | 0 | 0 |
|---|
| Non-operating expenses | - | 5 | 6 | 68 | 3 | 0 | 0 | 2 |
|---|
| Ordinary profit (loss) | -157 | -327 | -723 | 361 | -584 | -1,972 | 145 | -2,078 |
|---|
| Gain on sale of non-current assets | - | - | - | - | - | - | 0 | 0 |
|---|
| Gain on reversal of share acquisition rights | - | - | - | - | 8 | 26 | 25 | 59 |
|---|
| Extraordinary income | - | - | - | - | 8 | 26 | 25 | 59 |
|---|
| Profit (loss) before income taxes | -157 | -327 | -723 | 361 | -576 | -1,946 | 170 | -2,019 |
|---|
| Income taxes - current | -18 | 2 | 2 | 3 | 4 | 4 | 4 | 4 |
|---|
| Income taxes - deferred | -15 | -5 | -4 | 10 | 3 | -1 | -2 | -0 |
|---|
| Income taxes | -33 | -4 | -1 | 13 | 6 | 2 | 2 | 3 |
|---|
| Profit (loss) | -124 | -324 | -721 | 348 | -582 | -1,948 | 168 | -2,022 |
|---|